16.07.2024 13:33:13 | |
---|---|
2,62 EUR | |
-0,76% (-0,02) |
ISIN | BE0974386188 |
Symbol | BTLS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 87 EUR |
Benchmark | BEL 20 INDEX |
- (0) | |
- (0) | |
2,64 EUR | |
2,64 EUR | |
2,62 EUR | |
2,64 EUR | |
- | |
0 | |
0,00 | |
3 | |
0 |
- | |
- |
Date | Headline | Download | |
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings | ||
2024/04/26 | Global Equity Ratings |
2024/07/16 13:33:13 | |
---|---|
Price | |
2.62 EUR | |
Difference | -0.76% (-0.02) |
ISIN | BE0974386188 |
Symbol | BTLS |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 87 EUR |
Benchmark | BEL 20 INDEX |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 2.64 EUR |
High | 2.64 EUR |
Low | 2.62 EUR |
Close (prev. day) | 2.64 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -40.05% | -55.44% | -64.40% |
Perf (abs.) | -1.75 | -3.26 | -4.74 |
Beta | 0.25 | 0.34 | 0.38 |
Volatility | 50.34 | 81.28 | 52.13 |
2,63 EUR (0) | |
2,74 EUR (23) | |
2,99 EUR (14) | |
3,77 EUR (34) | |
4,88 EUR (10.01.2024) | |
2,59 EUR (14.03.2024) | |
6,32 EUR (24.07.2023) | |
1,62 EUR (29.11.2023) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/07/16 | 21:50 | 2.67 EUR | 0.00 | 18 |
Duesseldorf | 2024/07/16 | 08:12 | 2.63 EUR | 0.00 | 1 |
Euronext Brussels | 2024/07/16 | 16:11 | 2.70 EUR | 0.03 | 25 |
Frankfurt | 2024/07/16 | 08:15 | 2.64 EUR | 0.00 | 2 |
Munich | 2024/07/16 | 08:29 | 2.70 EUR | 0.00 | 1 |
Stuttgart | 2024/07/16 | 13:33 | 2.62 EUR | 0.00 | 3 |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer